Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology-Reference-Cited by-同舟云学术

Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology

Published:2021-10 Issue: Volume:54-55 Page:101756
ISSN:1521-6918
Container-title:Best Practice & Research Clinical Gastroenterology
language:en
Short-container-title:Best Practice & Research Clinical Gastroenterology

Author:

Udomkarnjananun Suwasin^ORCID,Francke Marith I.,De Winter Brenda C.M.,Mulder Midas B.^ORCID,Baan Carla C.,Metselaar Herold J.,den Hoed Caroline M.^ORCID,Hesselink Dennis A.

Publisher

Elsevier BV

Subject

Gastroenterology

Reference139 articles.

1. Therapeutic drug monitoring - key to personalized pharmacotherapy;Oellerich;Clin Biochem,2017

2. Improving therapeutic decisions: pharmacodynamic monitoring as an integral part of therapeutic drug monitoring;Shipkova;Ther Drug Monit,2019

3. KDIGO clinical practice guideline for the care of kidney transplant recipients;Am J Transplant,2009

4. Immunological and pharmacological monitoring in the clinical use of cyclosporin A;Keown;Lancet,1981

5. Mycophenolate revisited;van Gelder;Transpl Int,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort;Scientific Reports;2024-08-30

2. Guidance on Selecting Optimal Steady-State Tacrolimus Concentrations for Continuous IV Perfusion: Insights from Physiologically Based Pharmacokinetic Modeling;Pharmaceuticals;2024-08-08

3. AI-Enhanced RAIN Protocol: A Systematic Approach to Optimize Drug Combinations for Rectal Neoplasm Treatment;2024-06-02

4. A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation;Asian Biomedicine;2024-06-01

5. Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method;Therapeutic Drug Monitoring;2024-04-19